These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 1770039)
1. Effect of a somatostatin analogue (SMS 201-995) on renal function and urinary protein excretion in diabetic rats. Igarashi K; Nakazawa A; Tani N; Yamazaki M; Ito S; Shibata A J Diabet Complications; 1991; 5(2-3):181-3. PubMed ID: 1770039 [TBL] [Abstract][Full Text] [Related]
2. Octreotide administration in diabetic rats: effects on renal hypertrophy and urinary albumin excretion. Flyvbjerg A; Marshall SM; Frystyk J; Hansen KW; Harris AG; Orskov H Kidney Int; 1992 Apr; 41(4):805-12. PubMed ID: 1513103 [TBL] [Abstract][Full Text] [Related]
3. Vasopressin contributes to hyperfiltration, albuminuria, and renal hypertrophy in diabetes mellitus: study in vasopressin-deficient Brattleboro rats. Bardoux P; Martin H; Ahloulay M; Schmitt F; Bouby N; Trinh-Trang-Tan MM; Bankir L Proc Natl Acad Sci U S A; 1999 Aug; 96(18):10397-402. PubMed ID: 10468619 [TBL] [Abstract][Full Text] [Related]
4. Octreotide administration in diabetic rats: effects on renal function and morphology. Usenmez T; Yildiz O; Oktenli C; Ozgurtas T; Kutlu M J Diabetes Complications; 2000; 14(1):53-9. PubMed ID: 10925067 [TBL] [Abstract][Full Text] [Related]
5. Effects of chronic administration of somatostatin analogue SMS 201-995 on the progression of chronic renal failure in subtotal nephrectomized rats. Uemasu J; Tokumoto A; Godai K; Kawasaki H; Hirayama C Exp Clin Endocrinol; 1990 Sep; 96(1):97-104. PubMed ID: 2279532 [TBL] [Abstract][Full Text] [Related]
6. Renal function in the noninsulin-dependent diabetic rat: effects of unilateral nephrectomy. Mozaffari MS; Warren BK; Russell CM; Schaffer SW J Pharmacol Toxicol Methods; 1997 Jun; 37(4):197-203. PubMed ID: 9279775 [TBL] [Abstract][Full Text] [Related]
7. Effect of octreotide and insulin on manifest renal and glomerular hypertrophy and urinary albumin excretion in long-term experimental diabetes in rats. Grønbaek H; Nielsen B; Osterby R; Harris A; Orskov H; Flyvbjerg A Diabetologia; 1995 Feb; 38(2):135-44. PubMed ID: 7536170 [TBL] [Abstract][Full Text] [Related]
8. Reduced glomerular hypertrophy by somatostatin analog, SMS 201-995, in the subtotal nephrectomized rats fed high-protein meals. Uemasu J; Godai K; Tokumoto A; Kawasaki H J Pharmacol Exp Ther; 1992 Feb; 260(2):505-8. PubMed ID: 1738100 [TBL] [Abstract][Full Text] [Related]
9. Renal effects of antihypertensive therapy in uninephrectomized diabetic rats. Gallego B; Flores O; López-Novoa JM; Pérez-Barriocanal F Res Exp Med (Berl); 1997; 197(4):199-209. PubMed ID: 9440138 [TBL] [Abstract][Full Text] [Related]
10. Effects of C-peptide on glomerular and renal size and renal function in diabetic rats. Samnegård B; Jacobson SH; Jaremko G; Johansson BL; Sjöquist M Kidney Int; 2001 Oct; 60(4):1258-65. PubMed ID: 11576340 [TBL] [Abstract][Full Text] [Related]
11. An inhibition of urinary albumin excretion by protease inhibitor in streptozotocin-diabetic rats. Ikeda T; Hoshino T Nephron; 1996; 74(4):709-12. PubMed ID: 8956306 [TBL] [Abstract][Full Text] [Related]
12. Effect of octreotide, captopril or insulin on renal changes and UAE in long-term experimental diabetes. Grønbaek H; Vogel I; Osterby R; Lancranjan I; Flyvbjerg A; Orskov H Kidney Int; 1998 Jan; 53(1):173-80. PubMed ID: 9453015 [TBL] [Abstract][Full Text] [Related]
13. Somatostatin analogue administration prevents increase in kidney somatomedin C and initial renal growth in diabetic and uninephrectomized rats. Flyvbjerg A; Frystyk J; Thorlacius-Ussing O; Orskov H Diabetologia; 1989 Apr; 32(4):261-5. PubMed ID: 2759363 [TBL] [Abstract][Full Text] [Related]
14. Effects of nephrectomy and high-protein diets on glomerular hemodynamics and urinary protein excretion in diabetic rats. Tilton RG; Pugliese G; Chang K; Kilo C; Williamson JR J Diabet Complications; 1988; 2(1):30-3. PubMed ID: 2968354 [TBL] [Abstract][Full Text] [Related]
15. C-peptide replacement improves weight gain and renal function in diabetic rats. Rebsomen L; Pitel S; Boubred F; Buffat C; Feuerstein JM; Raccah D; Vague P; Tsimaratos M Diabetes Metab; 2006 Jun; 32(3):223-8. PubMed ID: 16799398 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of both neutral endopeptidase and endothelin-converting enzyme by SLV306 reduces proteinuria and urinary albumin excretion in diabetic rats. Thöne-Reinke C; Simon K; Richter CM; Godes M; Neumayer HH; Thormählen D; Hocher B J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S76-9. PubMed ID: 15838365 [TBL] [Abstract][Full Text] [Related]
17. Long-term effects of a somatostatin analogue on renal haemodynamics and hypertrophy in diabetic rats. Muntzel M; Hannedouche T; Niesor R; Nöel LH; Souberbielle JC; Lacour B; Drüeke T Clin Sci (Lond); 1992 Nov; 83(5):575-81. PubMed ID: 1335394 [TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin subclasses in the urine of control and streptozotocin-induced diabetic rats and their role in the development of diabetic nephropathy. McDonald TL; Thiele GM Diabetes Res; 1990 Apr; 13(4):169-76. PubMed ID: 2134208 [TBL] [Abstract][Full Text] [Related]
19. Diabetic nephropathy in the rat: differing renal effects of an angiotensin converting enzyme inhibitor and a calcium inhibitor. Whitty MR; Jackson B Diabetes Res; 1988 Jun; 8(2):91-6. PubMed ID: 2852570 [TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of a growth hormone receptor antagonist (G120K-PEG) on renal enlargement, glomerular hypertrophy, and urinary albumin excretion in experimental diabetes in mice. Flyvbjerg A; Bennett WF; Rasch R; Kopchick JJ; Scarlett JA Diabetes; 1999 Feb; 48(2):377-82. PubMed ID: 10334317 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]